4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-18-018334
Director acquired 593,611 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RONNEBERG AMY L Director | 2018-06-25 | Conversion | +593,611 | 593,611 | I | ||
| Derivatives | |||||||
| RONNEBERG AMY L Director | 2018-06-25 | Conversion · Series B Preferred Stock | −1,287,100 | 0 | I | ||
| RONNEBERG AMY L Director | 2018-06-25 | Conversion · Series C Preferred Stock | −246,781 | 0 | I | ||
Loading xslF345X03/doc4.xml…